Skip to main content

Table 1 Hemodynamic and renal findings during baseline, development (DS) and intervention sepsis periods in the CG and AG groups

From: Cardiovascular effects of β-blockade in a sheep model of severe sepsis

  Group Baseline period Development sepsis period (DS) Sepsis intervention period P value
CO CG 3.68 (0.29) 3.68 (0.29) 4.12 (0.29) <0.001
  AG 3.21 (0.22) 3.21 (0.22) 5.63 (0.53)  
HR CG 66.0 (6.5) 66.0 (6.5) 108.8 (8.6) <0.001
  AG 59.7 (6.4) 59.7 (6.4) 111.6 (8.4)  
MAP CG 93.7 (5.1) 102.5 (3.6) 86.1 (4.1) 0.035
  AG 96.3 (5.0) 102.5 (3.8) 81.5 (4.3)  
RBF CG 217.3 (14.8) 217.3 (14.8) 324.8 (19.7) 0.194
  AG 214.7 (19.9) 214.7 (19.9) 292.3 (27.4)  
UO CG 31.1 (7.1) 84.1 (20.4) 22.1 (4.8) 0.097
  AG 34.8 (7.0) 52.3 (17.4) 16.8 (11.0)  
TPC CG 38.2 (3.4) 38.9 (3.4) 63.9 (6.8) 0.084
  AG 34.3 (3.1) 37.3 (3.2) 51.4 (6.8) <0.001
SV CG 51.4 (3.7) 39.1 (3.6) 35.5 (8.2) 0.147
  AG 51.2 (4.6) 36.7 (3.5) 39.6 (3.6)  
RVC CG 2.39 (0.18) 3.26 (0.26) 3.74 (0.41) 0.55
  AG 2.23 (0.16) 2.88 (0.26) 3.53 (0.44)  
  1. Values are the mean (± standard error). P value: two-way repeated-measures ANOVA interaction between treatment group and time (see text for definitions).